India Isosorbide Mononitrate Market (2024-2030) Outlook | Value, Companies, Industry, Forecast, Share, Trends, Revenue, Analysis, Size & Growth

India Isosorbide Mononitrate Market Synopsis

The Indiaisosorbide mononitrate market is expected to register a CAGR of 8.9% over the forecast period (2023-2029). The rising prevalence of cardiovascular diseases, coupled with growing demand for long acting nitrates in the management of angina pectoris and heart failure are among some of the key factors driving growth in this market. Additionally, increasing geriatric population and rising awareness about better health care initiatives have been adding to the overall growth potential for the India isosorbide mononitrate market.

Market Drivers

Government initiatives to provide affordable healthcare facilities and easy availability through online pharmacies is aiding the growth of this market further. However, generic drugs possessing similar effects can hamper the growth prospects for brands selling Isosorbide Mononitrate at premium prices. Also, stringent regulatory policies may hinder its sales in certain parts of India due to lack or absence of approval from relevant authorities like DCGI (Drugs Controller General Of India). Nevertheless, expansion into untapped rural areas will create new opportunities for players operating within this industry landscape over the forecast period 2023-2029.

Challenges of the Market

Certain drawbacks such as high costs associated with product development stages along with limited availability may hinder the overall growth prospects for this industry during 2019-2025. Furthermore, stringent regulation by government authorities regarding quality standards have also been impacting market performance negatively. Moreover, COVID-19 pandemic has made a considerable impact on global business activities due to disruption in supply chain & logistics which will eventually lead to reduced revenue generation from sales activity across different sectors including healthcare drugs and medicines sector as well.

Key Players in the Market

Major players operating in India isosorbide mononitrate industry include Sanofi Aventis Pharma Private Limited., Pfizer Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Abbott Healthcare Pvt Ltd., Torrent Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd., Wockhardt Ltd., Ranbaxy Laboratories Limited etc.

Key Highlights of the Report:

• India Isosorbide Mononitrate Market Outlook
• Market Size of India Isosorbide Mononitrate Market, 2023
• Forecast of India Isosorbide Mononitrate Market, 2030
• Historical Data and Forecast of India Isosorbide Mononitrate Revenues & Volume for the Period 2020-2030
• India Isosorbide Mononitrate Market Trend Evolution
• India Isosorbide Mononitrate Market Drivers and Challenges
• India Isosorbide Mononitrate Price Trends
• India Isosorbide Mononitrate Porter's Five Forces
• India Isosorbide Mononitrate Industry Life Cycle
• Historical Data and Forecast of India Isosorbide Mononitrate Market Revenues & Volume By By Type for the Period 2020-2030
• Historical Data and Forecast of India Isosorbide Mononitrate Market Revenues & Volume By 10 mg Tablet for the Period 2020-2030
• Historical Data and Forecast of India Isosorbide Mononitrate Market Revenues & Volume By 20 mg Tablet for the Period 2020-2030
• Historical Data and Forecast of India Isosorbide Mononitrate Market Revenues & Volume By By Application for the Period 2020-2030
• Historical Data and Forecast of India Isosorbide Mononitrate Market Revenues & Volume By Treatment of angina pectoris for the Period 2020-2030
• Historical Data and Forecast of India Isosorbide Mononitrate Market Revenues & Volume By Others for the Period 2020-2030
• India Isosorbide Mononitrate Import Export Trade Statistics
• Market Opportunity Assessment By By Type
• Market Opportunity Assessment By By Application
• India Isosorbide Mononitrate Top Companies Market Share
• India Isosorbide Mononitrate Competitive Benchmarking By Technical and Operational Parameters
• India Isosorbide Mononitrate Company Profiles
• India Isosorbide Mononitrate Key Strategic Recommendations